Analysis of Antihypertensive Treatment Efficacy

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00767247

Acronym

ATACA

Enrollment

2000

Registered

2008-10-07

Start date

2008-05-31

Completion date

2009-02-28

Last updated

2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension

Keywords

Arterial Hypertension

Brief summary

Analysis of antihypertensive treatment efficacy.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* arterial hypertension * intake of Atacand before study enrollment

Exclusion criteria

* hypersensitivity to candesartan or any other ingredient of Atacand * liver function impairment and/or cholestasis * severe renal insufficiency (serum creatinine \> 265 µmol/L) * Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Analysis of antihypertensive treatment efficacy.	measurement BP: 3 visits for 3 month

Countries

Russia

Outcome results